Results 161 to 170 of about 26,727 (247)

Characterization of Patients with COPD and GOLD E Classification in the United States. [PDF]

Int J Chron Obstruct Pulmon Dis
Bhatt SP, Zhang Y, White J, Stanford RH, Mayen Herrera E, Cunoosamy D, Djandji M, Soliman M, Qureshi T, Subramaniam A.   +9 more
europepmc   +1 more source

Target and off-target effects of vibegron on smooth muscle contraction of human detrusor and prostate tissues. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Hu S, Xu Y, Brandstetter M, Tamalunas A, Kale OE, Keller P, Stadelmeier LF, Weinhold P, Stief CG, Hennenberg M.   +9 more
europepmc   +1 more source

Rethinking asthma therapy, part 1: transdermal delivery of β₂-agonists. [PDF]

J Pharm Pharm Sci
Correa J, Brogden NK.
europepmc   +1 more source

Further Insights Into Anticholinergic Action Informed by Japanese Anticholinergic Risk Scale. [PDF]

Geriatr Gerontol Int
Mogi M, Liu S, Suzuki Y, Shibata Y, Yamada S.   +4 more
europepmc   +1 more source

Preclinical efficacy of the muscarinic agonist ML-007 in psychosis models depends on both M₁ and M₄ receptors. [PDF]

Neuropsychopharmacology
Chatterjee S, Soria M, Norville ZC, Thompson KR, Lillie J, Kreitzer AC, Wood MW.   +6 more
europepmc   +1 more source

Navigating the challenges of overactive bladder management in women. [PDF]

World J Urol
Braga A, Goldman HB, Padoa A, Serati M.
europepmc   +1 more source

Pharmacological and light-driven pupillary accommodation in guinea pigs: comparative effects of muscarinic modulators and illumination across developmental stages. [PDF]

Int J Ophthalmol
Wu H, Lu N, Qiao ZB, Cheng C, Luo WT, Wan T, Qiao T, Di Y.   +7 more
europepmc   +1 more source

Lung Function and the GOLD ABE Classification: Do We Need to "Go Back to the Future"? [PDF]

Open Respir Arch
Golpe R, Figueira-Gonçalves JM.
europepmc   +1 more source